DK0512090T4 - Behandling af inflammation - Google Patents

Behandling af inflammation

Info

Publication number
DK0512090T4
DK0512090T4 DK91920172T DK91920172T DK0512090T4 DK 0512090 T4 DK0512090 T4 DK 0512090T4 DK 91920172 T DK91920172 T DK 91920172T DK 91920172 T DK91920172 T DK 91920172T DK 0512090 T4 DK0512090 T4 DK 0512090T4
Authority
DK
Denmark
Prior art keywords
treatment
inflammation
cells
mast
mediators
Prior art date
Application number
DK91920172T
Other languages
English (en)
Other versions
DK0512090T3 (da
Inventor
Allan M Wachter
John Lezdey
Original Assignee
Sonoran Desert Chemicals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27416749&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0512090(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/683,620 external-priority patent/US5190917A/en
Application filed by Sonoran Desert Chemicals Llc filed Critical Sonoran Desert Chemicals Llc
Publication of DK0512090T3 publication Critical patent/DK0512090T3/da
Application granted granted Critical
Publication of DK0512090T4 publication Critical patent/DK0512090T4/da

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91920172T 1990-10-16 1991-09-26 Behandling af inflammation DK0512090T4 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59824190A 1990-10-16 1990-10-16
US64372791A 1991-01-18 1991-01-18
US07/683,620 US5190917A (en) 1986-12-24 1991-04-11 Treatment of psoriasis

Publications (2)

Publication Number Publication Date
DK0512090T3 DK0512090T3 (da) 1997-06-16
DK0512090T4 true DK0512090T4 (da) 2007-01-15

Family

ID=27416749

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91920172T DK0512090T4 (da) 1990-10-16 1991-09-26 Behandling af inflammation

Country Status (10)

Country Link
EP (1) EP0512090B2 (da)
AT (1) ATE146970T1 (da)
AU (1) AU679165B2 (da)
CA (1) CA2091354C (da)
DE (1) DE69123960T2 (da)
DK (1) DK0512090T4 (da)
ES (1) ES2096665T3 (da)
GR (1) GR3022533T3 (da)
OA (1) OA09768A (da)
WO (1) WO1992006706A1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4244735A1 (de) * 1992-08-24 1994-03-31 Behringwerke Ag Verwendung von C1-Inaktivator zur Bekämpfung von Komplikationen bei der Anwendung von Zytokinen, endogenen Mediatoren, gentechnisch produzierten Mediator-Hybriden oder Wachstumsfaktoren im Rahmen der therapeutischen Anwendung dieser Substanzen
US5837699A (en) 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US5939525A (en) * 1995-03-27 1999-08-17 Viron Therapeutics, Inc. Methods of treating inflammation and compositions therefor
US5614198A (en) * 1995-07-25 1997-03-25 The Trustees Of The University Of Pennsylvania Bowman-Birk Inhibitor compositions for treatment of inflammatory disease
DE19600480A1 (de) * 1996-01-09 1997-07-10 Beiersdorf Ag Verwendung von Serin-Proteinasen gegen Akne und entzündete Comedonen
US5780440A (en) * 1996-06-17 1998-07-14 Protease Sciences Inc. Treatment of pulmonary disease with protease inhibitors
EP0834556A1 (en) * 1996-09-25 1998-04-08 Academisch Ziekenhuis Leiden Methods for culturing cells
GB2318732A (en) 1996-11-01 1998-05-06 Johnson & Johnson Medical Wound healing compositions containing alpha-1-antitrypsin
JP2002526382A (ja) * 1998-04-01 2002-08-20 バイオテック・オーストラリア・ピーティーワイ・リミテッド 皮膚創傷の治療へのプロテアーゼ阻害剤の使用
EP1163900A1 (en) * 1998-11-05 2001-12-19 Protease Sciences, Incorporated Cosmetic compositions containing human type serine protease inhibitors
EP1150699A4 (en) * 1999-02-01 2004-06-30 John Lezdey TREATMENT OF BLADDER AND GASTROINTESTINAL MASTO CYTOSIS
JP2002537346A (ja) * 1999-02-22 2002-11-05 エリック・エフ・バーンスタイン 光老化の保護用組成物および保護方法
WO2001030389A1 (fr) 1999-10-26 2001-05-03 Japan Tissue Engineering Co., Ltd. Inhibiteurs de contraction de blessure
ES2243314T3 (es) 1999-10-27 2005-12-01 Alexandra Lucas Composiciones para la prevencion y el tratamiento del rechazo de trasplantes.
WO2001064031A2 (en) * 2000-03-01 2001-09-07 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Slpi knockout mice and methods for wound treatment
EP1365798B1 (en) 2000-09-29 2009-12-30 Viron Therapeutics, Inc. Use of serp-1 in combination with an immunosuppressant for treating arthritis
DK1392354T3 (da) * 2001-04-30 2005-07-04 Switch Biotech Ag Anvendelse af alpha-1-antichymotrypsin til fremstillingen af en sammensætning til behandling, forebyggelse eller diagnose af dårligt helende diabetiske sår
EP1390062A4 (en) * 2001-05-02 2005-09-14 Blood Res Center MODULATORS OF ELASTASE INHIBITOR SECRETION
GB0125594D0 (en) * 2001-10-25 2001-12-19 Univ Sheffield Inhibitors for inactivating allergens
EP1415664A1 (en) * 2002-10-30 2004-05-06 Switch Biotech Aktiengesellschaft Use of alpha 1-antichymotrypsin in combination with alpha-1-antitrypsin for treating/preventing diabetes associated or poorly healing arterial wounds
DE60328909D1 (de) * 2002-11-20 2009-10-01 Arriva Prometic Inc Zusammensetzung zur behandlung von ichthyosis unter verwendung von antitrypsin
PL2520654T3 (pl) 2003-08-26 2017-08-31 The Regents Of The University Of Colorado, A Body Corporate Inhibitory aktywności proteazy serynowej i ich zastosowanie w sposobach i kompozycjach do leczenia zakażeń bakteryjnych
WO2005056044A1 (en) * 2003-10-23 2005-06-23 Terry Du Clos Use of c-reactive protein to treat immune complex-mediated renal disease
GB0411145D0 (en) * 2004-05-19 2004-06-23 Imp College Innovations Ltd Protease inhibitors and their therapeutic applications
WO2005115385A1 (en) * 2004-05-24 2005-12-08 Ab Science Use of c-kit inhibitors for treating acne
US7285530B2 (en) 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent
WO2008060362A2 (en) * 2006-09-27 2008-05-22 The Regents Of The University Of California Methods and compositions for the treatment of skin diseases and disorders
EP2611459B1 (en) 2010-08-31 2019-12-11 Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. Alpha-1 antitrypsin-derived polypeptides for use in the treatment of inflammation
US9518107B2 (en) 2010-08-31 2016-12-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Pharmaceutical compositions containing polypeptides derived from α-1 antitrypsin and methods of use thereof
AU2012272636A1 (en) 2011-06-24 2013-05-02 Advent Bio Holdings Llc Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
AU2013202648B2 (en) 2012-01-10 2016-05-19 Konkuk University Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
BR112014027333A2 (pt) * 2012-05-01 2017-07-18 Univ Duke composição, métodos de tratamento ou melhora, de prevenção, e, de diagnóstico de uma condição prejudicial que está associada com o teor elevado de sulfato de heparano em um indivíduo que foi o receptor de um órgão, tecido ou células transplantados
AR094778A1 (es) 2013-02-13 2015-08-26 Laboratoire Français Du Fractionnement Et Des Biotechnologies Proteínas con glicosilación modificada y métodos para producirlas
US9801848B2 (en) * 2013-03-13 2017-10-31 The Regents Of The University Of California Prevention of rosacea inflammation
EP3487875A4 (en) * 2016-07-19 2020-02-12 Arete Discoveries, Inc. BIOMARKERS FOR THE DETECTION AND TREATMENT OF DISORDERS ASSOCIATED WITH THE ACTIVITY OF MASTOCYTES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0304971B1 (en) † 1982-08-13 1998-02-04 ZymoGenetics, Inc. A method of producing a polypeptide having the protease inhibition activity of mammalian alpha-1-antitrypsin
AU3145184A (en) * 1983-08-16 1985-02-21 Zymogenetics Inc. High expression of foreign genes in schizosaccharomyces pombe
US5093316A (en) † 1986-12-24 1992-03-03 John Lezdey Treatment of inflammation
US5008242A (en) * 1986-12-24 1991-04-16 John Lezdey Treatment of inflammation using 1-antichymotrypsin
US4916117A (en) * 1986-12-24 1990-04-10 John Lezdey Treatment of inflammation using alpha 1-antichymotrypsin
JP2656944B2 (ja) † 1987-04-30 1997-09-24 クーパー ラボラトリーズ タンパク質性治療剤のエアロゾール化

Also Published As

Publication number Publication date
AU679165B2 (en) 1997-06-26
EP0512090B1 (en) 1997-01-02
DE69123960D1 (de) 1997-02-13
EP0512090B2 (en) 2006-11-22
ATE146970T1 (de) 1997-01-15
CA2091354C (en) 2005-04-12
EP0512090A1 (en) 1992-11-11
DK0512090T3 (da) 1997-06-16
AU8929091A (en) 1992-05-20
GR3022533T3 (en) 1997-05-31
CA2091354A1 (en) 1992-04-17
ES2096665T3 (es) 1997-03-16
OA09768A (en) 1993-11-30
DE69123960T2 (de) 1997-05-07
EP0512090A4 (en) 1993-05-05
WO1992006706A1 (en) 1992-04-30

Similar Documents

Publication Publication Date Title
DK0512090T3 (da) Behandling af inflammation
EA200101166A1 (ru) Ингибиторы металлопротеаз
IT1138543B (it) L'applicazione in terapeutica dei derivati del 4,5,6,7-tetraidroisossazolo(5,4-c)piridin-3-olo come miotonolitici
PT92821A (pt) Processo para a preparacao composicoes farmaceuticas para o combate de doencas do tipo psoriase, bem como doencas inflamatorias, incorporando azelastina como substancia activa
ES2055406T3 (es) Composicion para el tratamiento de la inflamacion.
ATE3865T1 (de) Hydantoinamine und deren pharmazeutische zusammensetzungen.
DE68902798D1 (de) Verwendung von polymeren bei einer behandlung.
PT80820B (pt) Processo para a preparacao de derivados de 1,3-propilidenodifosfonato 2-substituidos
ES2058125T3 (es) Derivados de piperidina para el tratamiento del dolor.
DK0658110T3 (da) Anvendelse af norastemizol til behandling af allergisk rhinitis
ES2114117T3 (es) Acidos fenilalcan(en)oicos con actividad antagonista del leucotrieno b4.
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
DE68903092D1 (de) Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
ATE126061T1 (de) Verwendung von lithium zur behandlung oder prophylaxe von molluscum contagiusum.
ES2032922T3 (es) Empleo de los paf-aceter antagonicos para la fabricacion de un medicamento y procedimiento para determinar la eficacia de los mismos.
ES252138Y (es) Zapato ortopedico perfeccionado con punta automaticamente elevable al levantar el pie
SE8902607L (sv) Oxaza heterocykler och pharmaceutiska kompositioner innehaallande densamma
ES2166838T3 (es) 6-(triazolil(3-(trifluorometil)fenil)metil)-2-quinolinonas y -quinolinationas.
DK374584A (da) Analgetikum
DK0673646T3 (da) Anvendelse af deoxyspergualin til fremstilling af et lægemiddel til behandling af inflammatorisk-hyperreaktive sygdomme
MX9304878A (es) Uso de un azaspirano substituido en la fabricacion de un medicamento para utilizarse en el tratamiento de psoriasis.
IT8024862A0 (it) L'applicazione in terapeutica come agenti analgesici dei derivati del 4,5,6,7-tetraidroisossazolo (5,4-c)piridin-3-ol
DK0791355T3 (da) Fremgangsmåde til reduktion af vævsbeskadigelse forbundet med iskæmi
ECSP900632A (es) Antifungicidas oxazolidinones
MX9100918A (es) Empleo de glicerineteres como agentes auxiliares para la eliminacion del agua en productos solidos